ALLYN MCMILLAN: Open Payments
NPI 1457836140 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,310 in 190 payments from 20 companies in 2025. Trend: 2023 $2,689 · 2024 $2,933 · 2025 $3,310
Food & beverage: $3,310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $722 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $378 |
| Janssen Biotech, Inc. | 25 | $359 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $310 |
| Madrigal Pharmaceuticals | 13 | $281 |
| GENZYME CORPORATION | 9 | $228 |
| Aimmune Therapeutics, Inc. | 14 | $161 |
| QOL Medical, LLC | 5 | $148 |
| Lilly USA, LLC | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 6 | $118 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, REZDIFFRA, XIFAXAN, LINZESS, SKYRIZI.
Industry payments across TX — which companies pay providers there.
